Acute blood loss anemia remains a target for both clinical and coding validation. Why is that? We discuss current coding guidelines and clinical indicators for acute blood loss anemia. We discuss why coding and clinical denials for acute blood loss anemia are different and why different appeal strategies are necessary. And, as a special “twofer”, we also present a summary of clinical validation considerations and appeal strategies for a variety of diagnoses that are the target of payer audits.
Join us as we share what Denial Research Group/AppealMasters has learned over the years from appealing hundreds of coding and clinical validation denials for acute blood loss anemia and other popular diagnoses that were denied on a clinical basis. We reveal payer behaviors regarding auditing and denying these diagnosis codes. And, as always, we share proven, successful appeal strategies that you can use right away.
Learning Objectives:
- Understand common denial rationale
- Recognize the differences between coding and clinical denials
- Discover successful strategies to compose winning appeals when acute blood loss anemia and other common diagnoses are denied, even though you got it right
